On April 17, 2026, the Lungenklinik Hemer in Germany’s North Rhine-Westphalia region highlighted the critical importance of early detection and accurate diagnosis in treating respiratory conditions, particularly chronic obstructive pulmonary disease (COPD) and lung cancer. The clinic, located at Theo-Funccius-Straße 1 in Hemer, emphasized that timely intervention significantly improves patient outcomes, a message reinforced through its ongoing public health outreach and clinical excellence in pneumology.
The Lungenklinik Hemer operates as a specialized center for lung diseases, offering comprehensive services in pneumology, intensive care, sleep medicine, and thoracic oncology. According to its official department profile, the clinic treats thousands of patients annually, with inpatient cases numbering 6,732 in the most recent reporting period. Its medical team includes leading specialists such as PD Dr. Med. Michael Westhoff, who serves as Chief Physician for Pneumology with expertise in COPD, intensive care, and sleep medicine.
Dr. Westhoff’s leadership has been instrumental in advancing diagnostic precision and therapeutic innovation at the clinic. Under his direction, the pneumology department has prioritized early detection programs for lung cancer and COPD, utilizing advanced tools such as whole-body plethysmography and diffusing capacity tests to assess lung function with high accuracy. In the latest available data, the clinic performed 4,699 whole-body plethysmography procedures and 4,699 carbon monoxide diffusion analyses, underscoring its commitment to functional diagnostics.
The clinic’s diagnostic workload reflects a strong focus on malignant lung diseases. Among the top conditions treated, malignant neoplasms of the bronchus and lung (classified under ICD-10 codes C34.0, C34.1, C34.3, and C34.8) accounted for over 2,200 cases combined, making them the most frequently diagnosed conditions. This highlights the clinic’s role in managing one of Germany’s most prevalent and serious oncological challenges.
In addition to oncology, the Lungenklinik Hemer addresses chronic respiratory insufficiency, with 282 cases of chronic respiratory failure with hypoxia (J96.11) and 217 cases of other chronic obstructive pulmonary disease (J44.80) recorded. These figures illustrate the dual burden of obstructive lung disease and respiratory failure that the clinic routinely manages through integrated inpatient and outpatient care.
Dr. Michael Westhoff’s contributions extend beyond clinical practice into medical education and research. As a certified specialist in pneumology and a recognized authority in COPD management, he has participated in national guidelines development and supported training initiatives for respiratory therapists and junior physicians. His work aligns with broader German healthcare goals to reduce late-stage diagnoses through improved access to screening and specialist consultation.
The clinic’s emphasis on early detection is consistent with national public health strategies promoted by the German Cancer Research Center (DKFZ) and the Federal Joint Committee (G-BA), which advocate for low-dose computed tomography (LDCT) screening in high-risk populations, including long-term smokers over age 50. While the Lungenklinik Hemer does not currently operate a formal LDCT screening program based on publicly available information, its diagnostic infrastructure supports such initiatives through advanced imaging and pulmonary function testing capabilities.
Patient care at the clinic is further strengthened by its rehabilitation services, led by Erich Esch, Chief Physician for Pneumological Early Rehabilitation since July 1, 2002. This long-standing program ensures that patients recovering from acute exacerbations of COPD or post-surgical lung conditions receive structured, phased rehabilitation to improve lung function, exercise tolerance, and quality of life.
The Lungenklinik Hemer also maintains active collaborations with medical technology companies to evaluate emerging therapies. It participates in clinical assessments for bronchoscopic interventions such as endobronchial valve placement, a treatment option for select patients with severe emphysema. These efforts are coordinated through networks like those facilitated by Pulmonx, which lists certified centers offering Zephyr® Valve therapy based on physician training and procedural volume.
As of the latest available data, the clinic’s nursing staff comprises 119.04 full-time equivalents, supporting a physician team of 35.70 (including affiliated doctors). This staffing ratio reflects a commitment to multidisciplinary care, ensuring that patients receive continuous monitoring, education, and support throughout their treatment journey.
Public trust in the Lungenklinik Hemer is built on transparency and consistent clinical performance. The hospital regularly publishes its service metrics, including case volumes and treatment outcomes, enabling patients and referring physicians to assess its capabilities objectively. This openness supports informed decision-making, particularly for individuals seeking specialized care for complex lung conditions.
Looking ahead, the clinic continues to adapt to evolving respiratory health challenges, including the long-term effects of respiratory infections and the growing burden of environmentally linked lung diseases. Its focus on early diagnosis, combined with therapeutic innovation and rehabilitation, positions it as a key player in Germany’s pneumology landscape.
For individuals concerned about respiratory symptoms such as persistent cough, shortness of breath, or unexplained fatigue, the Lungenklinik Hemer advises prompt consultation with a pulmonologist. Early evaluation can distinguish between benign and serious conditions, opening the door to more effective and less invasive treatment options.
Those seeking updated information on the clinic’s services, physician specialties, or patient resources are encouraged to visit the official website of the Lungenklinik Hemer or contact the department directly via phone at 02372-908-2201.
Stay informed about developments in lung health and share this information to help others recognize the value of early detection. Comments and experiences are welcome below.